ロード中...
Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...
保存先:
| 出版年: | Anatol J Cardiol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Kare Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336859/ https://ncbi.nlm.nih.gov/pubmed/26301344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/akd.2015.6156 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|